• Je něco špatně v tomto záznamu ?

Silver Nanoparticles Stabilised by Cationic Gemini Surfactants with Variable Spacer Length

M. Pisárčik, J. Jampílek, M. Lukáč, R. Horáková, F. Devínsky, M. Bukovský, M. Kalina, J. Tkacz, T. Opravil,

. 2017 ; 22 (10) : . [pub] 20171023

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18033633

The present study is focused on the synthesis and investigation of the physicochemical and biological properties of silver nanoparticles stabilized with a series of cationic gemini surfactants having a polymethylene spacer of variable length. UV-VIS spectroscopy, dynamic light scattering, scanning electron microscopy and zeta potential measurements were applied to provide physicochemical characterization of the silver nanoparticles. The mean size values of the nanoparticles were found to be in the 50 to 115 nm range. From the nanoparticle size distributions and scanning electron microscopy images it results that a population of small nanoparticles with the size of several nanometers was confirmed if the nanoparticles were stabilized with gemini molecules with either a short methylene spacer (two or four -CH₂- groups) or a long spacer (12 -CH₂- groups). The average zeta potential value for silver nanoparticles stabilized with gemini molecules is roughly independent of gemini surfactant spacer length and is approx. +58 mV. An interaction model between silver nanoparticles and gemini molecules which reflects the gained experimental data, is suggested. Microbicidal activity determinations revealed that the silver nanoparticles stabilized with gemini surfactants are more efficient against Gram-negative bacteria and yeasts, which has a direct relation to the interaction mechanism of nanoparticles with the bacterial cell membrane and its structural composition.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18033633
003      
CZ-PrNML
005      
20181010125002.0
007      
ta
008      
181008s2017 sz f 000 00|eng||
009      
AR
024    7_
$a 10.3390/molecules22101794 $2 doi
035    __
$a (PubMed)29065563
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pisárčik, Martin $u Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinčiakova 8, Bratislava SK-83232, Slovakia. pisarcik@fpharm.uniba.sk.
245    10
$a Silver Nanoparticles Stabilised by Cationic Gemini Surfactants with Variable Spacer Length / $c M. Pisárčik, J. Jampílek, M. Lukáč, R. Horáková, F. Devínsky, M. Bukovský, M. Kalina, J. Tkacz, T. Opravil,
520    9_
$a The present study is focused on the synthesis and investigation of the physicochemical and biological properties of silver nanoparticles stabilized with a series of cationic gemini surfactants having a polymethylene spacer of variable length. UV-VIS spectroscopy, dynamic light scattering, scanning electron microscopy and zeta potential measurements were applied to provide physicochemical characterization of the silver nanoparticles. The mean size values of the nanoparticles were found to be in the 50 to 115 nm range. From the nanoparticle size distributions and scanning electron microscopy images it results that a population of small nanoparticles with the size of several nanometers was confirmed if the nanoparticles were stabilized with gemini molecules with either a short methylene spacer (two or four -CH₂- groups) or a long spacer (12 -CH₂- groups). The average zeta potential value for silver nanoparticles stabilized with gemini molecules is roughly independent of gemini surfactant spacer length and is approx. +58 mV. An interaction model between silver nanoparticles and gemini molecules which reflects the gained experimental data, is suggested. Microbicidal activity determinations revealed that the silver nanoparticles stabilized with gemini surfactants are more efficient against Gram-negative bacteria and yeasts, which has a direct relation to the interaction mechanism of nanoparticles with the bacterial cell membrane and its structural composition.
650    _2
$a antiinfekční látky $x farmakologie $7 D000890
650    _2
$a houby $x účinky léků $7 D005658
650    _2
$a gramnegativní bakterie $x účinky léků $7 D006090
650    _2
$a kovové nanočástice $x chemie $7 D053768
650    _2
$a micely $7 D008823
650    _2
$a stříbro $x chemie $7 D012834
650    _2
$a povrchově aktivní látky $x chemie $7 D013501
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jampílek, Josef $u Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Bratislava SK-83232, Slovakia. josef.jampilek@gmail.com.
700    1_
$a Lukáč, Miloš $u Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinčiakova 8, Bratislava SK-83232, Slovakia. lukac@fpharm.uniba.sk.
700    1_
$a Horáková, Renáta $u Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinčiakova 8, Bratislava SK-83232, Slovakia. horakova@fpharm.uniba.sk.
700    1_
$a Devínsky, Ferdinand $u Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, Kalinčiakova 8, Bratislava SK-83232, Slovakia. devinsky@fpharm.uniba.sk. Faculty of Pharmacy, Comenius University, Kalinčiakova 8, Bratislava SK-83232, Slovakia. devinsky@fpharm.uniba.sk.
700    1_
$a Bukovský, Marián $u Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, Bratislava SK-83232, Slovakia. bukovsky@fpharm.uniba.sk.
700    1_
$a Kalina, Michal $u Materials Research Centre, Faculty of Chemistry, Brno University of Technology, CZ-61200 Brno, Czech Republic. kalina-m@fch.vut.cz.
700    1_
$a Tkacz, Jakub $u Materials Research Centre, Faculty of Chemistry, Brno University of Technology, CZ-61200 Brno, Czech Republic. tkacz@fch.vut.cz.
700    1_
$a Opravil, Tomáš $u Materials Research Centre, Faculty of Chemistry, Brno University of Technology, CZ-61200 Brno, Czech Republic. opravil@fch.vutbr.cz.
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 22, č. 10 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29065563 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181010125451 $b ABA008
999    __
$a ok $b bmc $g 1340951 $s 1030627
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 22 $c 10 $e 20171023 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Možnosti archivace